PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Saint Luke\'s Mid America Heart Institute, Kansas City, MO, USA; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: mkosiborod@saint-lukes.org.\', \'Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.\', \'Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Instituto do Coracao do Hospital das Clinicas da FMUSP, Sao Paulo, Brazil.\', \'Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.\', \'Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'National University of Córdoba, Córdoba, Argentina.\', \'Experimental Medicine and Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, UK.\', \'Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St Michael\'s Hospital, Toronto, ON, Canada; Department of Surgery and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.\', \'Max Super Speciality Hospital, New Delhi, India.\', \'Saint Luke\'s Mid America Heart Institute, Kansas City, MO, USA.\', \'George Clinical Inc, Overland Park, KS, USA.\', \'Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil.\', \'Division of Pulmonary and Critical Care, Saint Luke\'s Health System, Kansas City, MO, USA.\', \'Hospital Regional Hans Dieter Schmidt, Joinville, Brazil.\', \'PROCAPE, Recife, Brazil.\', \'Hospital Coracao do Brasil, Brasília, Brazil.\', \'Department of Endocrinology, Diabetes and Metabolism, Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA; Mississippi Center for Clinical and Translational Research, Jackson, MI, USA.\', \'North Shore University Health System, Evanston, IL, USA.\', \'Washington University School of Medicine, St Louis, MO, USA.\', \'Hospital Mãe de Deus, Porto Alegre, Brazil.\', \'Irmandade Da Santa Casa de Misericórdia de Porto Alegre, Brazil.\', \'Heart Group of the Eastern Shore, Fairhope, AL, USA.\', \'Centro de Pesquisa Clínica do Coração, Aracaju, Brazil.\', \'Liga de Hipertensão Arterial -Universidade Federal de Goiás, Brazil; HCAMP-Secretaria Estadual de Saúde, Goiás, Brazil.\', \'Instituto de Investigaciones Aplicadas a la Neurociencia AC, Durango City, Mexico.\', \'Centro Integrado de Pesquisas, Hospital de Base, São José do Rio Preto, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2213-8587(21)00180-710.1016/S2213-8587(21)00180-7
?:doi
?:hasPublicationType
?:journal
  • The lancet. Diabetes & endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 34302745
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all